About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 77 record(s)
Req # A-2024-002
I noticed that pictures and names of risk leaders have been removed from CIB website. Are there any changes in risk team at CIB within last two year since joining of new head of board? What are the changes, any new persons joined or left CIB? Why those changes happened, what were the reasons? Were there any voluntary resignations or some persons asked by company to leave? What were the processes followed when new persons were hired and old persons left or removed? Were the new positions publicly advertised? How many persons applied to positions filled? How many persons were interviewed? Please provide all details related to hiring and end of job, for each role, no need to mention any names, provide each job title and all details of the reasons and complete processes followedOrganization: Canada Infrastructure Bank
July 2023
Req # A-2023-000312
The National Microbiology Laboratory‘s report on BTNX‘s 200 samples.Organization: Health Canada
July 2023
Req # A-2023-000341
2022 and 2023 Annual Report to the Head of Compliance and Enforcement as required under section 36 of the Work Place Harassment and Violence Prevention Regulations.Organization: Health Canada
July 2023
Req # A-2023-000449
The number of adverse reaction reports received by Health Canada for a neuroleptic drug from April 1, 2020 to March 31, 2023.Organization: Health Canada
July 2023
Req # A-2020-001753
Adverse Drug Reaction (ADR). Report number: E2B_03462673.Organization: Health Canada
July 2023
Req # A-2022-001099
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108621-44, Breast Implant Registry Considerations - Update.Organization: Health Canada
July 2023
Req # A-2023-000161
Adverse Drug Reactions (ADRs) for TEMODAL. Report numbers: E2B_03072550, E2B_02069473, E2B_02600423, E2B_02839770, E2B_03200196.Organization: Health Canada
July 2023
Req # A-2021-00351
Briefing Note 2021FIN506357 - Key Messages on Open Banking Advisory Committee ReportOrganization: Department of Finance Canada
July 2022
Req # A-2017-001792
The most recent Drug Establishment Licence for Auro Pharma including any annexes listing foreign buildings and the drugs they are licensed to produce.Organization: Health Canada
July 2022
Req # A-2018-000944
All documents describing any and all features of the "class exemption" issued by the Minister of Health under s. 56 of the Controlled Drugs and Substances.Organization: Health Canada
July 2022